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Abstract
A comparative study of the interaction of an antibiotic Tetracycline hydrochloride (TC) with two albumins, Human serum
albumin (HSA) and Bovine serum albumin (BSA) along with Escherichia Coli Alkaline Phosphatase (AP) has been presented
exploiting the enhanced emission and anisotropy of the bound drug. The association constant at 298 K is found to be two
orders of magnitude lower in BSA/HSA compared to that in AP with number of binding site being one in each case.
Fluorescence resonance energy transfer (FRET) and molecular docking studies have been employed for the systems
containing HSA and BSA to find out the particular tryptophan (Trp) residue and the other residues in the proteins involved
in the binding process. Rotational correlation time (hc) of the bound TC obtained from time resolved anisotropy of TC in all
the protein-TC complexes has been compared to understand the binding mechanism. Low temperature (77 K)
phosphorescence (LTP) spectra of Trp residues in the free proteins (HSA/BSA) and in the complexes of HSA/BSA have
been used to specify the role of Trp residues in FRET and in the binding process. The results have been compared with
those obtained for the complex of AP with TC. The photophysical behaviour (viz., emission maximum, quantum yield,
lifetime and hc) of TC in various protic and aprotic polar solvents has been determined to address the nature of the
microenvironment of TC in the protein-drug complexes.
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Introduction
The interaction of a protein with a drug or a toxic molecule is
usually studied by steady state and time-resolved quenching of Trp
emission of proteins. [1–15] In many cases the ligand (the drug or
the toxic molecule) which is usually a poor emitter in aqueous
medium exhibits enhanced emission due to interaction with
protein. In such cases, exploiting the ligand emission is advanta-
geous to study the interaction, since Trp emission in protein may
be partly quenched intrinsically by nearby residues due to subtle
change of conformation around the Trp residues in the protein-
ligand complex.
Steady state fluorescence, using selective excitation, along with
steady state and time-resolved anisotropy studies of Trp residues in
proteins and in the complexes of proteins with other molecules are
widely used to identify structural perturbation and other dynam-
ical information. [1] The other molecules include nucleic acid,
protein and suitable ligand, acting as drug or toxic molecule.
Although the fluorescence spectra of Trp residues in proteins are
usually broad, the position of the fluorescence maxima provides an
overall signature of Trp environment in proteins or in the
complexes of proteins. However, it is not possible to find the
contribution of individual Trp in the fluorescence spectra of multi
Trp proteins. The fluorescence lifetime even in a protein having
single Trp residue exhibits multiexponential decay. Thus it is also
difficult to assign the lifetime value to a particular Trp residue in
the free protein as well as in the complex of protein with other
molecules. [1].
The phosphorescence of Trp residues in proteins at 77 K in a
suitable cryosolvent forming a glassy matrix, on the other hand,
always appears as structured spectra with a definite (0,0) band,
characteristic of the Trp environment. [16–38] The position and
the width of the (0,0) band along with the overall structural
features of the spectra provide a definitive information regarding
the polarity, nature of the solvent exposure, the hydrophobicity
and the homogeneity of the immediate environment of the Trp
residue. The narrowness of the (0,0) bands of phosphorescence
spectra at 77 K is attributed to the smaller excited state dipole
moment of the lowest (p-p*) triplet state of Trp. [39] The blue-
shifted phosphorescence (0,0) band, typical of free Trp in a polar
solvent represents a Trp residue in polar environment with greater
solvent exposure. The red-shifted (0,0) phosphorescence band is
characteristic of a Trp residue located in a buried polarizable
environment with less solvent exposure. [9,17,39] Specific
interactions with polar residues, however, could result in blue-
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shifted origins for buried Trp residues. [17,40] In several cases
LTP spectra of multi Trp proteins exhibit more than one (0,0)
bands corresponding to different Trp residues present in the
protein. [17–38] This occurs if the Trp residues have widely
different local environment and the intramolecular singlet«singlet
nonradiative energy transfer (ET) between the different Trp
residues is inherently prevented due to special architecture of the
protein. The tyrosine (Tyr) residues in proteins also exhibit a broad
phosphorescence spectra within 350–450 nm region with
lexc = 280 nm provided Tyr-Trp intramolecular energy transfer
within the protein is prevented. [41].
Thus LTP of protein along with conventional steady-state and
time-resolved fluorescence spectra can provide a meaningful
understanding of protein-protein interaction, [34] protein-nucleic
acid interaction [42] and protein-ligand [13,20,43] interactions.
In this work we report the interaction of TC with serum
albumins (BSA/HSA) along with a comparative study with AP-TC
interaction. [20] The basic molecular structure of TC, discovered
in 1948 as natural fermentation products of a soil bacterium,
Streptomyces aureofaciens is shown in Figure 1. The ring structure
of TC is surrounded by upper and lower peripheral zones where
various chemical functional groups can be attached.[44–46] Apart
from its antibiotic activity, it also affects inflammation, immuno-
modulation, cell proliferation and angiogenesis. [47–49].
Serum albumins, the most abundant protein in the blood
stream, account for about 60% of the total plasma protein. The
most important physiological function of these proteins is to bind
and transport several exogenous and endogenous molecules like
fatty acids, nutrients, steroids, and sparingly soluble drugs. HSA is
a globular protein consisting of 585 amino acids and is cross linked
by seventeen disulfide bonds. It is considered to have three specific
domains, I, II, and III, each of which consists of two subdomains a
and b possessing common structural motifs. [50] HSA contains a
single tryptophan residue at 214.
A comparative study of the amino acid sequences of BSA and
HSA by Brown shows that they have similar general structural
features, the difference in sequence being generally conservative.
[51]The BSA molecule is made up of 3 homologous domains
which are divided into 9 loops by 17 disulfide bonds. BSA has two
tryptophan residues, Trp 134 in the first domain and Trp 213 in
the second domain. [52] BSA and HSA have 20 and 18 tyrosine
(Tyr) residues, respectively.
The functional form of the metalloenzyme AP consists of a
homo dimer with an appropriate mass of 94 KDa. [53–54]The
three metal ions (two Zn2+ ions and one Mg2+ ion) in the three
active sites of AP form a catalytic metal triad similar to that of the
phospholipase C from Bacillus cereus [55] and P1 nuclease from
Penicillium citrinum [56]. Each monomer of AP contains three
Trp residues at 109, 220 and 268. The three Trp residues have
been well characterised. The quasi-crystalline environment of the
buried Trp 109 is evidenced by the narrow bandwidth of the
optically detected magnetic resonance (ODMR) transition in zero
magnetic field.[18–19] The Trp 220 is found to be partially
exposed. [18–19] The emission of the Trp 268 is intrinsically
quenched due to its close proximity to Cys 286-Cys336. [18–19].
In this report we emphasize the following to unravel the
different features of interaction of TC with the three proteins:
(i) Evaluation of the binding constant from the enhanced
emission of bound TC and anisotropy of the bound TC.
(ii) FRET and the rate constants of energy transfer (ET) using
time resolved emission of the donor Trp in proteins and
also the emission of TC, acting as acceptor.
(iii) Time resolved anisotropy monitoring the emission of
bound TC to find the rigidity of the microenvironment
of TC imposed by binding.
(iv) Molecular docking studies of protein-TC complexes to find
the residues involved in the binding in each case and to
identify Trp residue involved in FRET.
(v) Phosphorescence study at 77 K to find the role of Trp/Tyr
residues in FRET.
(vi) Emission and anisotropy features of TC in various protic
and aprotic solvents to address the nature of the
microenvironment and the mechanism of the binding of
TC in the protein-TC complexes.
Experimental Procedures
2.1 Materials
The tetracycline hydrochloride (TC) and serum albumins (HSA
and BSA) were purchased from Sigma–Aldrich, USA. All the
solvents used were of spectral grade and further dried by standard
procedures. Phosphate buffer of pH 7 was prepared in triply
distilled water and used for making experimental solutions.
2.2 Steady State Measurements
UV-Vis absorption spectra were recorded on a Hitachi U-3210
spectrophotometer at 298 K. The steady state emission measure-
ments were carried out using a Hitachi Model F-4010 spectroflu-
orimeter equipped with a 150-W xenon lamp, at 298 K using a
Figure 1. Structure of (A) Tetracycline and (B)Tryptophan residue.
doi:10.1371/journal.pone.0060940.g001
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Figure 2. Steady State and Time Resolved Emission of TC in the Complexes with Proteins. (A)Fluorescence spectra of TC (25 mM) at 298 K
with varying concentration of BSA; curves (1–12) represents 0 mM,2.5 mM,5.0 mM,7.5 mM,10.0 mM,12.5 mM 15.0 mM,17.5 mM,20.0 mM,
25.0 mM,40.0 mM,60.0 mM BSA, respectively; lexc = 370 nm; excitation and emission band pass = 10 nm and 5 nm respectively. (B) Fluorescence
decay of TC (25 mM) at 298 K in aqueous buffer (pH 7), 25 mM BSA, 25 mM HSA, 25 mM AP; lexc = 370 nm; excitation and emission bandpass = 10 nm
each.
doi:10.1371/journal.pone.0060940.g002
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Figure 3. Variation of (I) fluorescence quantum yield (Q). (II) fluorescence anisotropy (r); (III) singlet state average lifetime (t) of TC (25 mM) in
aqueous buffer with increasing concentration of serum albumins. (A) for BSA, (B) for HSA.
doi:10.1371/journal.pone.0060940.g003
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Table 1. Singlet State Lifetime and Quantum Yield of TC (25 mM) as a Function of Added Concentration of Serum Albumins with
lex = 370 nm at 298 K.
System lmax (nm) Quantum Yield (Qf)610
3 Singlet State Lifetime
t1 t2 tav (ns) x
2
Free TC (25 mM) Broad ,515.0 0.26 1.60(5.1%) 0.30(94.9%) 0.37 1.17
+2.5 mM BSA 506.4 0.46 1.90(7.4% ) 0.46(92.6%) 0.57 0.99
+5.0 mM BSA 502.8 0.68 1.99(13.6%) 0.63(86.4%) 0.81 1.10
+10.0 mM BSA 501.4 0.95 2.11(20.0%) 0.76(80.0%) 1.03 1.01
+15.0 mM BSA 500.6 1.23 2.52(21.5%) 0.99(78.5%) 1.32 1.00
+20.0 mM BSA 500.2 1.28 2.6(23.6%) 1.02(76.4%) 1.39 1.15
+25.0 mM BSA 498.4 1.55 2.62(22.8%) 1.11(77.2%) 1.4 0.99
+2.5 mM HSA 496.0 0.28 1.95(3.0%) 0.49(97.0%) 0.54 1.06
+5.0 mM HSA 492.8 0.31 2.18(4.1%) 0.51(95.8%) 0.58 1.18
+10.0 mM HSA 490.0 0.44 2.72(7.7%) 0.69(92.3%) 0.85 1.01
+15.0 mM HSA 489.8 0.48 3.04(9.9%) 0.87(90.1%) 1.07 0.99
+20.0 mM HSA 489.8 0.58 3.05(11.0%) 0.95(89.0%) 1.18 1.2
+25.0 mM HSA 489.8 0.70 3.22(11.2%) 0.96(88.8%) 1.20 1.1
doi:10.1371/journal.pone.0060940.t001
Figure 4. The plot of (A) (I) [F‘ 2 F0]/[Fx 2 F0] against [BSA]
21(II) (r2rf)/R(rb2r) against [BSA]; (B) (I) and (II) similar plot for HSA.
doi:10.1371/journal.pone.0060940.g004
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stopper cell of 1 cm path length. Fluorescence quantum yield (Q)
was determined in each case by comparing the corrected emission
spectrum of the samples with that of quinine sulfate in 0.1 N
H2SO4 (QD = 0.54) [57] considering the total area under the
emission curve.
The measurement of steady state anisotropy was performed in
Hitachi Model F-7000 spectrofluorimeter with manual Glen
Thompson polarizer. The steady state anisotropy (r) is defined by
r~ IVV{G  IVHð Þ= IVVz2G  IVHð Þ ð1Þ
where IVV and IVH are the intensities obtained with the excitation
polarizer orientated vertically and the emission polarizer oriented
vertically and horizontally, respectively. The G factor is defined as
G~IHV=IHH ð2Þ
‘I’ terms refer to the parameters similar to those mentioned above
for the horizontal position of the excitation polarizer and vertical
and horizontal position of the emission polarizer, respectively.
Steady state anisotropy measurement at room temperature was
done using F-7000 Hitachi spectrofluorimeter. [58].
2.3 Low Temperature Phosphorescence Measurement
Emission studies at 77 K were made using a Dewar system
having a 5 mm o.d. quartz tube. The freezing of the samples at
77 K were done at the same rate for all the samples.
Phosphorescence was measured in a Hitachi F-7000 spectrofluo-
rimeter equipped with phosphorescence accessories. All the
samples were made in 40% EG-water for measurements at
77 K. The samples were excited at different wavelengths (280 nm
and 295 nm) using a 10 nm band pass, and the emission band pass
was 1 nm.
2.4 Time Resolved Emission Measurements
Singlet state lifetime was measured by Time Master fluorimeter
from Photon Technology International (PTI,USA).The system
consists of a pulsed laser driver of a PDL series i.e, PDL-800-B
(from Picoquant, Germany) with interchangeable sub nano second
pulsed LEDs and pico-diode lasers (Picoquant, Germany) with a
TCSPC set up (PTI,USA). The software Felix 32 controls all
acquisition modes and data analysis of the Time Master system.
[59] Decay measurement using ‘magic angle’ detection with an
emission polarizer set at 55o were carried out and no detectable
difference in the fitted t values with those obtained from normal
decay measurements were observed. The sample of 25 mM TC
with different concentration of HSA and BSA were excited using
PLS-370 (Pulse Width-600 ps) and diode laser LDH-405(Pulse
Width-70 ps) respectively at a repetition frequency 10 MHz.
Instrument response function (IRF) were measured at the
respective excitation wavelengths, namely, 370 and 405 nm using
slits with a band pass of 3 nm using Ludox as the scatterer. The
decay of sample was analyzed by nonlinear iterative fitting
procedure based on the Marquardt algorithm. Deconvolution
technique used can determine the lifetime up to 200 ps with sub
nano second pulsed LEDs and 100 ps with diode lasers. Intensity
decay curves were fitted as a sum of exponential terms: [1].
F tð Þ~Saiexp {t=tið Þ ð3Þ
where ai represents the pre-exponential factor to the time resolved
decay of the component with a lifetime ti. The decay parameters
were recovered using a nonlinear iterative fitting procedure based
on the Marquardt algorithm. The quality of fit has been assessed
over the entire decay, including the rising edge, and tested with a
plot of weighted residuals and other statistical parameters, e.g., the
reduced x2 ratio and the Durbin–Watson (DW) parameters. [59]
Mean lifetime,t.for biexponential decays were calculated using
the equation: [59]
vtw~(a1t1za2t2)=(a1za2) ð4Þ
Table 2. Binding Constant (Kb) and Free Energy Change (DG) Associated with Binding Following Different Methods at 298 K.
System Method Binding Constant (M21) Binding Site (n) Free Energy(Kcal/mol)
Experimental Theoretical
HSA-TC Modified Bensi-Hildebrand 3.146104 – 26.17 26.84
Steady State Fluorescence
anisotropy
4.496104 –
Steady State Fluorescence
Quenching
4.946104 5.386104a 1
BSA-TC Modified Bensi-Hildebrand 4.726104 – 26.55 27.38
Steady State Fluorescence
anisotropy
5.976104 –
Steady State Fluorescence
Quenching
6.26104 7.216104a 1
AP-TCb Modified Bensi-Hildebrand 6.86106 – 29.05 28.49
Steady-state fluorescence
anisotropy
1.96106 –
Steady State Fluorescence
Quenching
3.96106 at 298 K 1
aRef [66].
bRef [20].
doi:10.1371/journal.pone.0060940.t002
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Anisotropy decay measurement was also carried out in Time
Master Fluorimeter (PTI, USA) using PLS-370 and motorized
Glen Thompson polarizer. The anisotropy, r(t) is defined as
r tð Þ~ IVV tð Þ-G  IVH tð Þ½ = IVV tð Þz2G  IVH tð Þ½  ð5Þ
where I(t) terms are defined as intensity decay of emission of TC
with excitation polarizer orientated vertically and the emission
polarizer oriented vertically and horizontally, respectively:
G~IHV tð Þ=IHH tð Þ ð6Þ
where, G is the correction term for the relative throughput of each
polarization through the emission optics. The entire data analysis
was done with the software Felix 32 which analyses the raw data
IVV and IVH simultaneously by global multi-exponential
program and then the deconvolved curves (IDVV and IDVH)
are used to construct r(t) [59] and from the fitted curve the
correlation time (hC) can be recovered.
2.5 Docking Studies
The crystal structure of HSA (PDB entry 1AO6) and BSA (PDB
entry 4F5S) were downloaded from the Protein Data Bank. [60]
The three-dimensional structure of the tetracycline molecule was
obtained from Sybyl 6.92 (Tripos Inc., St. Louis, USA) and the
energy-minimized structure was achieved using a Tripos force field
and Gasteiger-Hu¨ckel charges with a gradient of 0.005 kcal/mol.
The dielectric constant, number of iteration, maximum displace-
ment, minimum energy change, simplex threshold and simplex
iteration were set to 1.0, 1000, 0.01, 0.05, 1000 and 20
respectively. The FlexX single molecule docking software was
used to dock tetracycline with chain A of alkaline phosphatase.
The ranking of the generated solutions was obtained from a
scoring function as mentioned by Rarey et al. [61] PyMol was
used to visualize the docked conformation and to measure the
distances between the ligand and the protein. [62].
2.6 Accessible Surface Area Calculations
The ASA (accessible surface area) of HSA and BSA (free) and
the docked complexes with tetracycline were calculated using
Figure 5. Docked poses of serum albumin-TC complexes. (A) The surrounding amino acid residues of (I) BSA (II) HSA within 5 A˚ from TC. (B)
Distances (in A˚) obtained from docked poses of different Trp residue/s of (I) BSA (II) HSA from TC.
doi:10.1371/journal.pone.0060940.g005
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NACCESS. [63] The best docked structure according to the
minimum energy was chosen to determine the ASA of the docked
proteins. The change in accessible surface area for residue i was
calculated using the following equation.
DASAi~ASA
i
HSA=BSA{ASA
i
HSA=BSA{TCcomplex
A residue was considered to be involved in the binding if it lost
more than 10 A˚2 ASA when going from the free state to the
complexed state. PEARLS (Program of Energetic Analysis of
Receptor Ligand System) was used to estimate the energetics of the
protein-ligand interaction. [64].
Results and Discussion
3.1 Steady State and Time Resolved Emission of TC in the
Complexes with Proteins
The quantum yield of the free TC in aqueous buffer is found to
be very small (Figure 2(A) Table 1). Figure 2(A) represents the
emission spectra of TC (25 mM) as a function of increasing
concentration of BSA using lexc = 370 nm. There has been a
steady increase in the emission intensity of TC in the presence of
serum albumins. The maximum of the drug emission is shifted
towards blue from ,515.0 nm in the free TC to 498.4 nm in the
complex with increasing protein concentration. The similar
behaviour is also observed for HSA-TC system. On comparison
it has been observed that QHSA-TC, QBSA-TC, QAP-TC. [20] The
lifetime of the probe TC has been also measured as a function of
added concentration of serum albumins monitoring the enhanced
emission maxima in each case using lexc = 370 nm and also
lexc = 405 nm (Table 1). The decays were found to fit with two
components with the fitting parameter x2 close to 1 in each case
demonstrating the quality of fit. The representative decay profiles
for the three complexes of proteins with TC are presented in
Figure 2B. The average lifetime increases from 0.37 ns in free TC
in aqueous buffer to 1.2 ns and 1.4 ns in HSA-TC and BSA-TC
complexes respectively using both the excitations at 370 nm and
405 nm (Table 1, Figure 3).
3.2 Binding Constant and Number of Binding Sites
3.2.1 From Steady State Emission and Anisotropy of
Bound TC. Although the binding constants of protein-drug
complexes are usually determined from quenching of Trp
fluorescence, methods exploiting the drug emission is always
desirable. It is to be noted that Trp emission in protein could be
perturbed not only due to bound drug molecule, but also by
nearby residues of Trp due to a subtle change of conformation
around Trp in the protein-drug complex. Thus we determined the
binding constant from the enhanced fluorescence intensity of TC
as a function of added protein concentration employing modified
Benesi–Hilderbrand equation [65].
FF0½ = FxF0½ ~1z1=K L½  ð7Þ
Table 3. The Changes in Accessible Surface Area (DASA)a of
the Residues of Serum Albumins after Complexed with
Tetracycline.
HSA-TC BSA-TC
RESIDUE DASA (A˚2) RESIDUE DASA (A˚2)
Lys195 240.43 Arg 194 225.87
Trp214 227.02 Arg 217 239.58
Arg218 237.41 Glu 291 239.5
Glu294 224.71 Lys 294 229.52
Asn295 220.28 Val342 218.45
Lys444 212.48 Lys439 215.50
Pro447 217.38 Glu443 214.16
Cys448 234.80 Asp450 239.41
Asp451 230.12
Tyr452 218.98
Val455 211.22
Total loss of ASA 2274.83 Total loss of ASA 2221.99
aDASAi = ASA
i
HSA/BSA – ASA
i
HSA/BSA – TC complex.
doi:10.1371/journal.pone.0060940.t003
Table 4. Distances and of Tryptophan Residues of Different Proteins from TC Changes in Accessible Surface Area (DASA) of
Tryptophan Obtained by the Docking Studies.
Distance (A˚) from BSA Trp 213 BSA Trp 134 HSA Trp 214 AP Trp 109 AP Trp 220 AP Trp 268
indole N to O attached with
3-C
10.00 30.42 6.25 34.10 6.52 46.02
indole N to 5-C 10.74 26.46 8.6 30.67 5.56 44.8
indole N to O attached with
10-C
12.13 20.84 12.21 24.23 7.57 40.23
indole N to 12-C 9.63 25.67 8.01 28.66 4.99 42.07
C1 to N attached with 4-C 13.76 30.99 10.15 35.41 9.00 47.58
C1 to O attached with 6-C 14.20 27.68 12.20 31.10 8.77 44.63
C1 to O attached with 11-C 11.30 24.72 10.50 36.08 8.56 46.82
ASA (Protein) (A˚2) 40.9 15.4 61.7 1.0 52.7 46.7
ASA (complex)(A˚2) 40.9 15.4 34.7 1.0 29.1 46.7
DASA (A˚2) 0 0 27.0 0 23.6 0
doi:10.1371/journal.pone.0060940.t004
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where, F0, Fx, and F‘ are the fluorescence intensity of the
enhanced emission of TC considered in the absence of protein, at
an intermediate protein concentration, and at a concentration of
complete interaction, respectively. K is the binding constant and
[L] is the concentration of added protein (HSA and BSA). A plot
of [F‘2F0]/[Fx2F0] against the [L]
21 provides the binding
constant (K) from the slope. Such a plot for the complex of TC
with serum albumins is found to be linear (Figure 4) and the
binding constants are given in Table 2.
We have also measured steady state anisotropy (r) of TC in the
complexes at emission maxima as a function of concentration of
proteins. (Figure 3) The data has been analyzed using the equation
(8)
r rfð Þ=R rb rð Þ~Kb P½ 
where, R~Qb=Qf
ð8Þ
where, Qf and Qb are the quantum yield of the free TC and the
protein bound to drug, respectively, rf and rb are the anisotropy
observed for free TC and after complete complex formation with
protein. A linear plot of (r2rf )/R(rb–r) vs [P] provides the binding
constant (Figure 4, Table 2).
3.2.2 From Steady State and Time Resolved Quenching of
Trp Emission. The fluorescence quenching of proteins due to
the addition of TC using lexc = 290 nm was analyzed according to
the following general equation: [31].
F=F0~af i=( 1zKSV,i L½ ð Þ exp Ki L½ ð Þ ð9Þ
where, F and F0 are the corrected fluorescence intensities in the
presence and in the absence of drug TC, respectively, fi is the
fractional intensity corresponding to quenching site component i.
Ksv,i is the dynamic quenching constant for the component i, Ki is
the static quenching constant for component i, and [L] is the total
quencher concentration. [31] Inclusion of the exp (Ki[L]) term in
the above equation applies in cases where there is an upward
curvature in a Stern-Volmer (F0/F vs [L]) plot, due to static
quenching. The fluorescence quenching data for the protein-drug
complex was fitted to equation 9 (taking i = 1 and fi = 1 for 1:1
complex and assuming single site quenching) with inclusion of the
static quenching term. The values of the binding constant which
are in good agreement with the values obtained by other authors
[66–67], are given in Table 2.
The binding constants determined from the steady state
anisotropy data and Benesi–Hilderbrand equation monitoring
the enhanced emission of the bound drug are compared with that
obtained from the fluorescence quenching monitoring Trp
emission of the serum albumins (Table 2). [66–67] The binding
constants are found to be two orders of magnitude smaller than
that obtained for AP-TC complexes. [20].
3.3 Molecular Docking Studies: Nature of Different
Residues Involved in the Interaction
Molecular docking studies were performed to support the
experimental data and provide some insight into the protein-drug
interactions. Calculations of the ligand–receptor interaction
energy from docking studies have been obtained using PEARLS.
For all three protein-TC complexes, the lowest score was taken
in a FlexX run that corresponded to the best docking pose. This
docked pose refers to lowest binding free energy conformation
(best rank conformation) of a protein-ligand complex. This also
met the criteria set for at least two consecutive minimum score
values within 0.05 of each other. The number of conformations
occupying the same site was also considered and it was observed
that the occupancy of the specific site of docking was at least over
50%. The best rank conformation of each of the three complexes
are used to evaluate our experimental findings.
The theoretical DG0 values are in close agreement with the
experimental values in all the cases [Table 2]. We find that AP
(DG0 =28.49 kcal mol21) exhibits a higher affinity than BSA
(DG0 =27.58 kcal mol21) and HSA (DG0 =26.84 kcal mol21).
The docked conformation of TC in the complexes serum
albumin-TC are shown in Figure 5. Table 3 shows the different
residues of serum albumins which lose over 10 A˚2 in ASA upon
binding with TC. Apart from these residues, Leu 198, Gln 221,
Val 293, Tyr 341, Ser 342, Val 343, Lys 436, Ser 454 are also
within 5 A˚ from the bound TC for the HSA-TC complex.
Similarly, the residues Ala 290, Glu 339, Ala 341, Pro 446, Cys
447 are also found to be present within 5 A˚ from the bound TC
for the BSA-TC complex. It is also noticed that the residues Lys
195, Arg 218, Gln 221, Glu 294, Asn 295, Ser 342, Lys 436, Lys
444, Cys 448, Asp 451, Tyr 452, Ser 454 make polar contacts with
the probe TC in the HSA-TC complex. The residues Arg 194, Arg
217, Lys 294, Glu 339, Val 342, Asp 450 are found to make polar
contacts with TC in the BSA-TC complex. Thus, it has been
observed that the number of residues involved in binding TC is
highest in the case of HSA-TC (Table 3, Figure 5) whereas in AP-
TC only six residues are around the drug. [20] The docked pose
indicates that TC binds in a buried region of HSA whereas the
Table 5. The Energy Transfer Efficiency and The Rate Constant of Protein-TC Complexes at 298 K.
Method ET efficiency Rate of ET (k ET)610
8
Ratio of (k ET) (HSA/
BSA)
Theoritical Ratio of
(k ET) (HSA/BSA)
Eqn 11 Eqn 12 Eqn 11 Eqn 12
HSA BSA HSA BSA HSA BSA
i) Using Donor quenching 0.42
0.48 a
0.45
0.47 a
2.15 1.673 4.0 3.36 1.28 1.19 1.18b
ii) Using Acceptor enhancement 0.50 0.55 2.37 2.33 4.21 3.81 1.02 1.105
iii) Using Phosphorescence
quenching
0.33 0.35 1.14 1.01 0.76 0.66 1.13 1.15
aRef [66].
bConsidering the distance from indole N of Trp to O attached with 10-C of TC.
doi:10.1371/journal.pone.0060940.t005
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binding regions are partly buried and solvent exposed in the case
of BSA and AP respectively. [20].
The distances of Trp residues of the three proteins from TC and
the changes in accessible surface area (DASA) of Trp residues are
summarized in Table 4.
3.4. Energy Transfer (FRET) in the Protein-TC Complexes
The steady-state and the time resolved quenching of serum
albumins by TC are utilized to determine the energy transfer
efficiency (E) in both the complexes of BSA and HSA using
E~1{ FD{A=FDð Þ ð10aÞ
where, FD and FD-A are the fluorescence intensities of the proteins
in the absence and in the presence of drug TC.
Since there is no overlap of the donor (Trp) emission and the
emission of TC, E is also determined monitoring the enhancement
of the emission of the acceptor TC using the following equation:
Figure 6. Phosphorescence spectra of (A) (a) 10 mM BSA and (b) BSA-TC (1:1) complexes, (B)(a)10 mM HSA and (b) HSA-TC (1:1)
complexes in 40% EG matrix at 77 K; lexc =280 nm. Excitation band pass = 10 nm and emission band pass = 1 nm for each case.
doi:10.1371/journal.pone.0060940.g006
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E~ FAD=FA{1ð ÞeA lDexð Þ=eAD(lAD ex) ð10bÞ
where, FA and FAD are the fluorescence intensities of the acceptor
TC in the absence and in the presence of donor serum albumins
with excitation at 280 nm. eA (lD
ex) and eAD (lAD
ex) are the
extinction coefficient of the acceptor TC at 280 nm in the absence
and in the presence of donor serum albumins. The energy transfer
efficiencies for the serum albumins calculated by donor quenching
and acceptor enhancement are given in Table 5. The greater value
of energy transfer efficiency obtained (0.51 from donor quenching)
in AP-TC complex [20] reflects that the probe molecule resides
nearer to the Trp residue in AP than that in the case of serum
albumins. Docking results discussed in section 3.3 also support this
view.
The rate constant of the energy transfer (kET) has been
evaluated using
kET~E= tD 1{Eð Þf g ð11Þ
and
kET~E=tD{A ð12Þ
where, tD and tD2A represents the average lifetime for the donor
and the complex (after full complexation). The kET values thus
obtained are provided in Table 5.
The rate constants kET, in s
21, for energy exchange between
two species coupled by the Fo¨rster transfer mechanism [68–69] is
given by
kET~ 8:71 | 10
23
 
k0r0
{6k2n{4Q J ð13Þ
where, k0 is the decay constant for the donor in the absence of the
acceptor, Q is the radiative quantum yield in the absence of energy
transfer, r is the distance between the centres of the donor and the
acceptor (in A˚), n is the refractive index of the medium, J is the
overlap integral between the donor luminescence and the acceptor
absorption spectrum, and k2 is the orientation factor for the
dipole-dipole interaction.
Assuming J, n, Q, and k2 to be same for the systems HSA-TC
and BSA-TC, one can calculate the ratio of the kET in the two
systems using the donor-acceptor distance (r) obtained from the
docking studies and the average lifetime of the donor (,tD.).
kETð ÞHSA{TC
 
= kETð ÞBSA{TC
 
~ vtDw½ BSA rð Þ6
h i
BSA{TC
n o
= vtDw½ HSA rð Þ6
h i
HSA{TC
n o ð14Þ
The theoretical ratio of kET for serum albumin-TC complexes
using the distance between the indole N to O attached with 10-C
of TC as donor-acceptor distance (Figure 5B) is presented in
Table 5. The result calculated is compared with the experimental
ratio of the kET. Although the transition dipole moment direction
Table 6. Phosphorescence Data for Wild-Type Serum Albumins and its Complex with TC in a 40% Ethylene Glycol Matrix at 77 K
(lexc = 280 nm).
System Position of the phosphorescence (0,0) band (nm)
Width of the phosphorescence (0,0) band at half-maxima
(cm21)
Free BSA 10 mM) 412.8 270
BSA-TC (10:10) 413.4 305
Free HSA 10 mM) 410.0 332
HSA-TC (10:10) 410.6 320
doi:10.1371/journal.pone.0060940.t006
Figure 7. Fluorescence anisotropy decays of TC (25 mM) at 298 K in 25 mM has. IVV and IVH represent decays of emission of TC with
excitation polarizer at vertical position and emission polarizer at vertical and horizontal position, respectively. lexc = 370 nm; excitation and emission
band pass = 10 nm each.
doi:10.1371/journal.pone.0060940.g007
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of Trp is known, the direction of the transition dipole moment of
TC is not known. Thus it is difficult to predict the actual values of
orientation factor k2 and the exact distance ‘r’ for the donor-
acceptor pair in the complexes. Considering this limitation, a good
correlation between the theoretical ratio and the experimental
ratio of kET values supports the distances obtained from docking
studies.
3.5 Phosphorescence Spectra: Role of Trp and Tyr
Residues in the Interaction
The phosphorescence spectra of free serum albumins and their
complexes with TC in 40% EG glassy-matrix at 77 K are
compared in Figure 6. The phosphorescence spectra in both the
complexes are quenched compared with those of free proteins.
HSA contains a lone Trp residue at the position 214, which
shows a phosphorescence (0,0) band at 410.0 nm. Upon binding to
TC, there is a small but definitive red shift of the (0,0) band
(Table 6). This indicates that Trp 214 experiences more
hydrophobic environment upon binding. This result is also
supported by the docking studies which indicates that a substantial
loss of the ASA of Trp 214.
Although BSA possesses two tryptophan residues, Trp 213 and
Trp 134, the (0,0) band appears as a single peak at 412.8 nm and
the two Trp residues cannot be optically resolved. However, BSA
shows two distinct (0,0) bands upon binding with suitable fatty acid
(406.1 nm and 414.1 nm), [70] 3-hydroxy Naphthoic Acid
(405.6 nm and 412.8 nm), [43] catechin/epicatechin (403.8 nm
and 412.0 nm) [71]. The blue shifted band is attributed to Trp 134
of BSA. In the BSA-TC complex, LTP shows only one (0,0) band
at 413.4 nm indicating that Trp 134 is not at all perturbed in this
interaction. The position of the (0,0) band for the BSA-TC
complex is also slightly red shifted compared to that in free BSA.
The slight difference in band widths of the (0,0) bands (Table 6)
indicates that the Trp environments in free serum albumins and in
their complexes are not similar in homogeneity.
The ET efficiency calculated from the Trp phosphorescence
spectra of the free albumins and their complexes with
lexc = 295 nm (where Tyr is not excited) is found to be 0.33 for
HSA and 0.35 for BSA (Table 5) using equation:
E~1{ ID{A=IDð Þ ð15Þ
where, ID and ID-A represent the area under the total phospho-
rescence spectra of the proteins in the absence and in the presence
of drug TC respectively.
It is to be noted that although the non-radiative ET takes place
at the singlet level, E values obtained from phosphorescence data
at 77 K are in fairly good agreement with those calculated from
the fluorescence data at room temperature (Table 5) and thus
support our earlier conclusions. Quantitative agreement should
not be expected, since ET may differ for fluid and rigid solvent
media.
A similar study with AP showed that only Trp 220 among the
three Trp residue is involved in the interaction with TC. [20] In
the case of free serum albumins and their complexes with TC, an
unstructured underlying emission originating near 350 nm was
observed in the spectrum, which is assigned to Tyr residues. [41]
For AP-TC complex the contribution of tyrosine phosphorescence
appearing below 400 nm was found to be diminished consider-
ably. [20] This result thus indicates that Tyr residues are not
involved in the ET process in the interaction between serum
albumins and TC.
3.6. Time Resolved Anisotropy of TC in the Complexes:
Rotational Correlation Time
The anisotropy decays of TC in the different complexes with
proteins HSA (Figure 7) and BSA are measured using
lexc = 370 nm and lexc = 405 nm. The rotational correlation
Figure 8. Steady State and Time Resolved Emission of TC in
Various Solvents. (A) Fluorescence spectra of TC (25 mM) at 298 K in
(1) water, (2) ethanol (EtOH), (3) isopropanol (iPrOH), (4) ethylene glycol
(EG), (5) dimethylformamide (DMF), (6) dimethyl sulphoxide (DMSO);
lexc = 370 nm; excitation and emission band pass = 10 nm and 5 nm
respectively. (B) Fluorescence decay of TC (25 mM) at 298 K in (B) EtOH,
iPr-OH, EG, DMF, DMSO; lexc = 370 nm; excitation and emission
bandpass = 10 nm each.
doi:10.1371/journal.pone.0060940.g008
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Figure 9. Plot of Q (A) and ,t. (B) against (I) dielectric constant (e), (II) solvent polarizability parameter (p*), (III) Hydrogen bond
donating ability (a) of different solvents, (1) DMSO, (2) DMF, (3) EG, (4) EtOH, (5) i-PrOH.
doi:10.1371/journal.pone.0060940.g009
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times (hc) are recovered from the fitted curves (Table 7). The
results confirm that the enhancement of quantum yield of the
probe TC in the complex is due to motional restriction imposed on
the probe due to binding. The maximum value of hc (6 ns)
observed for HSA–TC compared to that in BSA–TC (hc = 5 ns)
and in AP-TC (hc = 3.6 ns) correlates well with the docking results
where we find highest number of perturbed residues around the
drug in HSA-TC complex (Table 3).The results also imply the
buried nature of the binding site of TC in the case of HSA. This
imposes restriction of rotational motion of TC leading to the
enhanced value of hC. The faster rotational correlation time of TC
in AP-TC is in conformity with the solvent exposed nature of the
drug chromophore. [20] BSA-TC complex exhibits intermediate
value of hC confirming the partial exposed environment of TC
(Table 3).
3.7 Steady State and Time Resolved Emission of TC in
Various Solvents Exploring the Nature of the
Microenvironments of Bound TC in the Complexes
In order to understand the details of the microenvironment of
TC in all the protein-TC complexes we carried out the steady state
and time resolved fluorescence of TC monitoring the lmax of the
emission of TC in various solvents as shown in Figure 8A and 8B
respectively. The quantum yield (W) and the lifetime (t) of the
Figure 10. Fluorescence anisotropy decays of TC (25 mM) at 298 K in pure EG. IVV and IVH represent decays of emission of TC with excitation
polarizer at vertical position and emission polarizer at vertical and horizontal position, respectively. lexc = 370 nm; excitation and emission band
pass = 10 nm each.
doi:10.1371/journal.pone.0060940.g010
Table 7. Photophysical Data of TC Obtained by Monitoring the Emission Maxima in Different Medium and in the Complexes with
Proteins at 298 K (lexc = 370 nm).
System
(TC in)
lem
(nm) W (x103) Singlet state lifetime (ns)
Rotational
correlation
time hc(ns)
(kr x10
26)
s21
(knr610
29)
s21 Solvent Parrameters
t1 t2 tav x
2 p* a b e
DMSO 523.0 2.49 2.78 (18.24%) 1.53 (81.76%) 1.76 1.01 2.3 1.41 0.57 0.98 0.00 0.76 45.00
DMF 524.0 1.69 2.08 (9.81%) 0.91 (90.19%) 1.02 1.11 1.4 1.66 0.98 0.88 0.00 0.69 38.00
EG 530.0 1.44 1.93 (21.14%) 0.74 (78.86%) 0.99 0.99 3.4 1.46 1.01 0.88 0.90 0.52 37.00
EtOH 545.5 0.72 1.51 (13.78%) 0.58 (86.22%) 0.71 1.00 2.3 1.01 1.41 0.54 0.83 0.77 24.55
i-PrOH 548.0 0.52 1.87 (2.13%) 0.49 (97.87%) 0.52 1.20 3.0 1.00 0.92 0.48 0.76 0.95 18.00
Water Broad
,515
0.26 1.6 (5.06%) 0.3 (94.94%) 0.36 1.17 – 0.71 2.73 1.09 1.17 0.18 80.0
HSA 490.0 0.70 3.22 (11.2%) 0.96 (88.8%) 1.20 1.10 6.0 6.2a 0.59 0.83 – – – –
BSA 498.0 1.55 2.62 (22.8%) 1.11 (77.2%) 1.45 0.99 5.0 4.9a 1.07 0.69 – – – –
AP 509.0 2.30 2.79 (10%) 0.39 (90%) 0.63 0.90 3.6 3.5a 3.43 1.49 – – – –
aThe value obtained using lexc = 405 nm.
doi:10.1371/journal.pone.0060940.t007
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emission of TC in various polar protic and aprotic solvents have
been provided in Table 7. The quantum yield and the singlet state
lifetime are found to be higher in polar aprotic solvents compared
to that in polar protic solvents (Table 7). The influence of solvent
polarizability parameter p*, hydrogen bond donating ability (a)
and hydrogen bond accepting ability (b) of different solvents on the
emission of TC is studied using Kamlet–Taft multi-parameter
approach. [72] In the plot of W vs dielectric constant (e) and the
average lifetime,t. vs. e, an increasing trend with increasing e is
observed (Figure 9). Plots of W and ,t. with p* show gradual
enhancement of W and ,t. with increasing p*(Figure 9). The
parameter b, however, does not exhibit any such correlation. For
polar protic solvents, we observed a linear trend in the plot of W vs
a and ,t. vs. a (Figure 9). These results imply that the polarity,
the polarizability and the hydrogen bond donating ability of the
surrounding residues control the emission quantum yield of TC in
the protein-TC complex apart from the motional restriction of
bound TC in the complexes. The radiative (kr) and the non-
radiative (knr) rate constants of the emission of TC in different
solvents and in the complexes of proteins have been calculated
(Table 7). The radiative rate constants vary for the different
protein-drug complexes. It is found that kr is maximum for AP-TC
and minimum for HSA-TC complex (Table 7). In DMSO where
the quantum yield is observed to be the highest, the nonradiative
rate constant is found to be 0.5761029 s21 compared to
2.7361029 s21 in water (Table 7). Rotational correlation time
measured from fluorescence anisotropy decay are given in Table 7.
A representative decay in EG is shown in Figure 10. The
rotational correlation time, hC, is found to be maximum in EG
among all the solvents used for study. Measurement of rotational
correlation time of TC in aqueous buffer, however, is beyond our
present detection limit.
Conclusions
The steady state and time resolved studies monitoring the
enhanced emission of bound TC at 298 K, the phosphorescence
spectra of the free proteins and the protein-TC complexes at 77 K
and the molecular docking studies are used to explore the
interaction between the widely used antibiotic TC and proteins
HSA, BSA. The results have been compared with those found for
AP-TC complex. The studies reveal the following:
(i) The number of binding site is one for each protein and the
binding constant at 298 K is of the order of <104 for
serum albumins, whereas for AP-TC it is two orders of
magnitude greater.
(ii) The TC emission is enhanced in the complex of proteins
with Q(AP-TC). Q(BSA-TC) .Q(HSA-TC). The experimental
ratio of the ET rate constants [(kET)HSA-TC/(kET)BSA-TC]
agree well with the ratio calculated using the distance and
the orientation of the donor-acceptor obtained from the
docking results. In the case of HSA and BSA, Trp 214 and
Trp 213 are involved in the ET process respectively. The
docking results and the phosphorescence spectra reveal
that Trp 134 for BSA is not taking part in the ET process.
The Tyr residues in both serum albumins are also found to
be not involved in the interaction.
(iii) Docking studies reveal that the number of residues in the
binding region of TC and the total loss of ASA of different
residues is maximum for HSA-TC complexes, whereas in
the case of AP-TC the number of residues perturbed was
found to be minimum. This observation indicates that TC
is bound in a buried region in HSA, partly buried region
for BSA and solvent exposed region in AP. This is also
supported by the rotational correlation time of TC in
different complexes ([hC]HSA-TC .[hC]BSA-TC.[hC]AP-TC).
(iv) The emission maxima, the quantum yield, the lifetime and
the rotational correlation time of the probe TC in various
pure solvents imply that the polarity, the polarizability and
the hydrogen bond donating ability of the neighbouring
residues of TC along with the motional restriction of
bound TC govern the enhanced emission of TC in
different protein-TC complexes.
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